KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZN) Pension (2016 - 2025)

Astrazeneca has reported Pension over the past 11 years, most recently at $1.1 billion for Q4 2025.

  • Quarterly results put Pension at $1.1 billion for Q4 2025, down 16.92% from a year ago — trailing twelve months through Dec 2025 was $1.1 billion (down 16.92% YoY), and the annual figure for FY2025 was $1.1 billion, down 16.92%.
  • Pension for Q4 2025 was $1.1 billion at Astrazeneca, down from $1.3 billion in the prior quarter.
  • Over the last five years, Pension for AZN hit a ceiling of $2.5 billion in Q4 2021 and a floor of $1.1 billion in Q4 2025.
  • Median Pension over the past 5 years was $1.3 billion (2024), compared with a mean of $1.5 billion.
  • Biggest five-year swings in Pension: tumbled 52.4% in 2022 and later skyrocketed 30.14% in 2023.
  • Astrazeneca's Pension stood at $2.5 billion in 2021, then tumbled by 52.4% to $1.2 billion in 2022, then surged by 30.14% to $1.5 billion in 2023, then fell by 12.5% to $1.3 billion in 2024, then dropped by 16.92% to $1.1 billion in 2025.
  • The last three reported values for Pension were $1.1 billion (Q4 2025), $1.3 billion (Q4 2024), and $1.5 billion (Q4 2023) per Business Quant data.